NutraLife BioSciences, Inc. (NLBS)

NutraLife BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	-	13	14	8	17
Market Cap Growth	-	-	-8.75%	63.63%	-50.99%	-63.43%
Enterprise Value	-	-	16	17	10	17
PE Ratio	-	0	-1.65	-4.79	-2.09	-8.36
PS Ratio	-	-	20.24	11.07	3.98	4.67
PB Ratio	0	0	-17.80	46.17	5.35	21.26
P/FCF Ratio	-	-	-26.03	-10.82	-1.88	-21.23
P/OCF Ratio	-	-	-26.03	-10.82	-2.90	-73.86
EV/Sales Ratio	-	-	25.04	13.58	4.92	4.62
EV/EBITDA Ratio	-	-	-3.79	-6.87	-2.78	-9.14
EV/EBIT Ratio	-	-	-3.51	-5.93	-2.62	-8.83
EV/FCF Ratio	-	-	-32.20	-13.28	-2.32	-20.99
Debt / Equity Ratio	0	0	-4.41	10.48	1.27	0.27
Debt / EBITDA Ratio	-	-	-0.76	-1.27	-0.53	-0.12
Debt / FCF Ratio	-	-	-6.45	-2.46	-0.45	-0.27
Quick Ratio	0	0	0.03	0.04	0.01	0.46
Current Ratio	0	0	0.10	0.19	0.28	0.87
Asset Turnover	0	0	0.13	0.27	0.48	2.03
Interest Coverage	0	0	-2.42	-154.20	-428.44	-14.25
Return on Equity (ROE)	-	-	1078.30%	-963.99%	-256.33%	-254.47%
Return on Assets (ROA)	-	-	-158.38%	-61.67%	-91.21%	-113.34%
Return on Capital (ROIC)	-	-	-184.06%	-57.06%	-94.19%	-184.46%
Earnings Yield	-	-60.57%	-20.88%	-47.95%	-11.97%
FCF Yield	0.00%	-3.84%	-9.24%	-53.31%	-4.71%
Buyback Yield / Dilution	-	-12.43%	-29.18%	-29.72%	-21.59%
Total Shareholder Return	-	-12.43%	-29.18%	-29.72%	-21.59%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.